U.S. Drug Device Combination Products Market Size & Outlook
U.S. drug device combination products market, 2018-2030 (US$M)
Related Markets
U.S. drug device combination products market highlights
- The U.S. drug device combination products market generated a revenue of USD 46,715.3 million in 2023 and is expected to reach USD 78,343.8 million by 2030.
- The U.S. market is expected to grow at a CAGR of 7.7% from 2024 to 2030.
- In terms of segment, transdermal patches was the largest revenue generating product in 2023.
- Drug Eluting Stents is the most lucrative product segment registering the fastest growth during the forecast period.
Drug device combination products market data book summary
| Market revenue in 2023 | USD 46,715.3 million |
| Market revenue in 2030 | USD 78,343.8 million |
| Growth rate | 7.7% (CAGR from 2023 to 2030) |
| Largest segment | Transdermal patches |
| Fastest growing segment | Drug Eluting Stents |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Photodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters |
| Key market players worldwide | Abbott Laboratories, Terumo Corp, Stryker Corp, Viatris Inc, Medtronic PLC, Boston Scientific Corp, Novartis AG ADR, Becton Dickinson & Co, Teleflex Inc, W L Gore & Associates |
Other key industry trends
- In terms of revenue, U.S. accounted for 33.7% of the global drug device combination products market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. drug device combination products market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 20,415.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Drug Device Combination Products Market Scope
Drug Device Combination Products Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. drug device combination products market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.
Transdermal patches was the largest segment with a revenue share of 23.01% in 2023. Horizon Databook has segmented the U.S. drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing prevalence of chronic diseases and the rising number of cardiovascular surgeries in the U.S. are anticipated to propel the demand for drug-device combination products. In 2023, the U.S. accounted for the largest share of the drug device combination market in North America and is expected to maintain its dominance during the forecast period.
This can be attributed to high healthcare expenditure, increasing demand for innovative technologies, growing incidence of cancer, and surging awareness regarding early disease diagnosis. According to the American Cancer Society, in 2023, around 1,958,310 new cancer cases were diagnosed in the U.S., with around 609,820 related deaths. Hence, various initiatives undertaken by the American Cancer Society to create awareness about cancer types are expected to drive the adoption of diagnostic and treatment procedures.
Moreover, according to the National Cancer Institute, cancer mortality rates decreased by nearly 1.8% among men and 1.4% among women. In addition, the cancer survival rate has improved over the past few years, reflecting the quality of healthcare in the U.S., which is expected to contribute to market growth.
Reasons to subscribe to U.S. drug device combination products market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. drug device combination products market databook
-
Our clientele includes a mix of drug device combination products market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. drug device combination products market , including forecasts for subscribers. This country databook contains high-level insights into U.S. drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. drug device combination products market size, by product, 2018-2030 (US$M)
U.S. Drug Device Combination Products Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
